Shareholders back Bausch Health (NYSE: BHC) amended rights plan

Rhea-AI Filing Summary

Bausch Health Companies Inc. reported the results of a Special Meeting of Shareholders held on October 7, 2025. Shareholders voted on an ordinary resolution to ratify, confirm and approve the adoption of the company’s Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025 and amended and restated on August 25, 2025. The resolution was approved, with 178,244,775 votes cast for and 40,130,633 votes cast against. The Rights Plan Agreement is described in detail in the company’s Management Proxy Circular and Proxy Statement dated August 27, 2025.

Insights

Corporate governance analyst

Bausch Health shareholders approved an updated shareholder rights plan.

Shareholders of Bausch Health Companies Inc. approved an ordinary resolution ratifying, confirming and approving an Amended and Restated Shareholder Rights Plan Agreement. The plan dates back to April 14, 2025 and was amended and restated again on August 25, 2025, with details provided in the Management Proxy Circular and Proxy Statement dated August 27, 2025.

The voting results show 178,244,775 votes in favor and 40,130,633 votes against the resolution. This indicates a clear majority support for maintaining the rights plan framework as updated by the board. Such plans are typically used in the context of control and takeover situations, though specific mechanics are not detailed in this excerpt.

Because the resolution passed, the amended and restated Rights Plan Agreement remains in effect as approved by shareholders at the Special Meeting on October 7, 2025. Future company communications may further explain how the plan interacts with any potential strategic or control-related developments.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 10/09/2025 - 07:02 AM Learn about SEC filing dates

FAQ

What did Bausch Health (BHC) shareholders vote on at the Special Meeting?

Shareholders of Bausch Health Companies Inc. (BHC) voted on an ordinary resolution to ratify, confirm and approve the adoption of the company’s Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025 and amended and restated on August 25, 2025.

Did Bausch Health shareholders approve the Amended and Restated Shareholder Rights Plan Agreement?

Yes. Bausch Health shareholders approved the ordinary resolution ratifying, confirming and approving the adoption of the Amended and Restated Shareholder Rights Plan Agreement at the Special Meeting held on October 7, 2025.

What were the voting results on Bausch Health’s Rights Plan Agreement?

The resolution to approve the Rights Plan Agreement received 178,244,775 votes for and 40,130,633 votes against. This provided sufficient support to approve the ordinary resolution.

When was Bausch Health’s Special Meeting of Shareholders held?

The Special Meeting of Shareholders for Bausch Health Companies Inc. was held on October 7, 2025.

Where can investors find more detail on Bausch Health’s Rights Plan Agreement?

Details on the Amended and Restated Shareholder Rights Plan Agreement are provided in Bausch Health’s Management Proxy Circular and Proxy Statement dated August 27, 2025.

What type of filing reported Bausch Health’s shareholder vote on the rights plan?

The shareholder vote results on the Rights Plan Agreement were reported in a Form 8-K filed by Bausch Health Companies Inc. under Item 5.07, Submission of Matters to a Vote of Security Holders.

0000885590false00008855902025-10-072025-10-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

October 7, 2025

Date of report (Date of earliest event reported)

 Bausch Health Companies Inc.

(Exact name of registrant as specified in its charter)

British Columbia

,

Canada

001-14956

98-0448205

(State or other jurisdiction of incorporation)

(Commission file number)

(IRS Employer Identification No.)

2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8

(Address of Principal Executive Offices) (Zip Code)

(514) 744-6792

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Shares, No Par Value			BHC			New York Stock Exchange			Toronto Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐            

Item 5.07. Submission of Matters to a Vote of Security Holders.

On October 7, 2025, Bausch Health Companies Inc. (the “Company”) held a Special Meeting of Shareholders (the “Special Meeting”). At the Special Meeting, the shareholders of the Company voted on the approval of an ordinary resolution ratifying, confirming and approving the adoption of the Company’s Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025 (the “Rights Plan Agreement”), which is described in detail in the Company’s Management Proxy Circular and Proxy Statement dated August 27, 2025. The results of the matter voted upon are as follows:

Proposal No. 1: Approval of the Ratification, Confirmation and Approval of the Rights Plan Agreement

The shareholders approved the ordinary resolution ratifying, confirming and approving the adoption of the Rights Plan Agreement.

For						Against
178,244,775						40,130,633

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 9, 2025

			BAUSCH HEALTH COMPANIES INC.
By:			/s/ Seana Carson
			Seana Carson
			Executive Vice President, General Counsel